{"id":1611,"company":{"country":"US","currency":"USD","exchange":"NYSE MKT LLC","ipo":"2003-07-09","marketCap":12.615679740905762,"name":"Oragenics Inc","phone":"18132867900","outstanding":2.569999933242798,"symbol":"OGEN","website":"https://www.oragenics.com/","industry":"Biotechnology"},"price":4.76,"year":2023,"month":12,"day":12,"weekday":"Tuesday","title":"Ownership Structure of Oragenics Inc","date":"2023-12-12","url":"/posts/2023/12/12/OGEN","content":[{"section":"Institutional Investors","text":"As of the latest filing, institutional investors own around 45% of Oragenics Inc's stock. Some of the major institutional investors include BlackRock, Vanguard Group, and State Street Corporation. These institutions hold substantial positions in the company and demonstrate confidence in its long-term prospects."},{"section":"Insider Ownership","text":"Insider ownership in Oragenics Inc is relatively high, with insiders holding approximately 10% of the company's stock. Prominent insiders include the CEO, scientific advisors, and members of the board of directors. Their significant ownership aligns their interests with shareholders and indicates their belief in the company's success."},{"section":"Major Shareholders","text":"The major shareholders of Oragenics Inc include institutional investors like BlackRock, Vanguard Group, and State Street Corporation. Additionally, prominent insiders, such as the CEO and board members, hold significant stakes in the company. These major shareholders collectively own a considerable portion of Oragenics Inc's stock."}],"tags":["CrossOver55","Long","Biotechnology"],"news":null}